Emmaus Life Sciences Launches Its Commercial Co-Payment Assistance Program for Endari™

TORRANCE, Calif., Jan. 28, 2019 /PRNewswire/ — Emmaus Life Sciences, Inc. (Emmaus), a leader in sickle cell disease treatment, announced today that... Continue Reading